AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Ethris is developing mRNA-based candidates for the treatment of respiratory viral infections and rare pulmonary diseases, as well as prophylactic vaccines for mucosal, multivalent, and mutation-agnostic use.
- Dr. Rudolph discusses the challenges in the mRNA field, including regulatory considerations, cold-chain storage requirements, and the need for creative reimbursement models.
Deep dives
The Potential of COVID Vaccines and mRNA Paradigm
The podcast episode discusses the potential of entering the COVID vaccine market from a new vaccine paradigm. It highlights the driving forces of COVID, fatigue, and vaccine hesitancy behind the commercial acceptance of a new product.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode